Table 1.
Correlation between VPS9D1-AS1 expression and the clinicopathological characteristics of ESCC
| Clinical parameter | VPS9D1-AS1 | Chi-square test | |
|---|---|---|---|
| Low No. case (n=46) | High No. case (n=46) | p-value | |
| Age (years) | |||
| <60 | 21 | 25 | 0.404 |
| ≥60 | 25 | 21 | |
| Gender | |||
| Male | 37 | 36 | 0.797 |
| Female | 9 | 10 | |
| Smoking history | |||
| No | 26 | 21 | 0.297 |
| Yes | 20 | 25 | |
| Location | |||
| Upper | 2 | 2 | 0.977 |
| Middle | 26 | 25 | |
| Lower | 18 | 19 | |
| Histopathological grade | |||
| G1 | 10 | 3 | 0.008 * |
| G2 | 29 | 24 | |
| G3 | 7 | 19 | |
| Tumor invasion depth | |||
| T1 | 4 | 1 | 0.045* |
| T2 | 23 | 14 | |
| T3 | 14 | 19 | |
| T4 | 5 | 12 | |
| Lymph node metastasis | |||
| N0 | 26 | 11 | 0.005 * |
| N1 | 11 | 11 | |
| N2 | 7 | 19 | |
| N3 | 2 | 5 | |
| TNM stage | |||
| I | 9 | 2 | 0.008 * |
| II | 17 | 9 | |
| III | 15 | 22 | |
| IV | 5 | 13 | |